Hot Investor Mandate 4: Japan Based Pharma Looks Overseas for Pharma, Device and Home Healthcare Innovations

20 Jul

A pharma firm headquartered in Tokyo, Japan focuses on two main sectors: pharmaceutical and medical device for home healthcare. The company is seeking innovative medical technologies to strengthen its pipeline while expanding into new areas. The company is looking for in-licensing and collaborative R&D opportunities in the US, Canada, EU, and Israel.

The firm has existing businesses in respiratory diseases, cardiovascular disease, and orthopedics. The firm is seeking innovative, home-care, therapeutic medical devices in the disease sectors described above. The firm is also interested in home patient monitoring products. In addition, the firm is looking for innovations in the following areas: neurological disorders such as stroke, depression, Parkinson’s disease, etc.; cancer; wound care; and rehabilitation, which are all must be used at home care. The company is most interested in PMA and de novo therapeutic devices in the home-care settings. The company prefers assets with initial patient data. Furthermore, the firm is seeking opportunities in digital medicine business (but not for consumer products) in disease areas described above.

Within pharmaceuticals, the firm is looking for late clinical stage assets in orthopedics, respiratory diseases, and cardiovascular diseases. The firm is most interested in small molecule and peptide drugs.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: